Russell D Cohen, MD: Understanding the Role of Biosimilars in Healthcare
Russell D Cohen, MD, explains how biosimilars represent an opportunity to expand access and reduce the financial burden of high-cost biologics.
Stay updated with breaking news from Biosimilar Competition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Russell D Cohen, MD, explains how biosimilars represent an opportunity to expand access and reduce the financial burden of high-cost biologics.
In the last five years, ADCs deals have netted some of the biggest payouts in oncology drug development. The transactions signal excitement for the...
EU medicines regulators have for the first time published a statement supporting the interchangeability of biosimilar medicines in the EU.
In conversation with Dan Cohen, vice president and head of the Biosimilars Unit for Europe, Canada and partner markets at Biogen.
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today released the 9th edition of its Biosimilar Trends Report, which examines the current and future state of the U.S....